Autonomix Medical, Inc. financial data

Symbol
AMIX on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
21 Waterway Avenue, Suite 300, The Woodlands, TX
State of incorporation
DE
Fiscal year end
March 31
Latest financial report
10-Q - Q3 2024 - Nov 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 624 %
Debt-to-equity 129 %
Return On Equity -542 % +83.9%
Return On Assets -237 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.15M shares
Common Stock, Shares, Outstanding 1.15M shares
Common Stock, Value, Issued 1K USD
Weighted Average Number of Shares Outstanding, Basic 1.14M shares +65.4%
Weighted Average Number of Shares Outstanding, Diluted 13.8M shares +15%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
Research and Development Expense 3.51M USD +149%
General and Administrative Expense 7.41M USD +110%
Operating Income (Loss) -10.9M USD +51.3%
Nonoperating Income (Expense) -3.1M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -14M USD +53.5%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -14M USD -73%
Earnings Per Share, Basic 5.19 USD/shares +71.9%
Earnings Per Share, Diluted -0.23 USD/shares -360%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.16M USD
Other Assets, Current 199K USD
Assets, Current 5.35M USD
Property, Plant and Equipment, Net 17K USD
Assets 5.37M USD
Accounts Payable, Current 574K USD
Accrued Liabilities, Current 683K USD
Liabilities, Current 1.26M USD
Other Liabilities, Noncurrent 4.97M USD
Liabilities 2.34M USD
Retained Earnings (Accumulated Deficit) -44.5M USD
Stockholders' Equity Attributable to Parent 3.03M USD
Liabilities and Equity 5.37M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.85M USD -180%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities -5K USD
Common Stock, Shares Authorized 500M shares
Common Stock, Shares, Issued 1.15M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.86M USD -190%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.22M USD +50.4%
Deferred Tax Assets, Valuation Allowance 3.46K USD +136%
Deferred Tax Assets, Gross 3.46K USD +136%
Payments to Acquire Property, Plant, and Equipment 5K USD
Deferred Tax Assets, Operating Loss Carryforwards 2.64K USD +96.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares
Additional Paid in Capital 47.5M USD
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 43K USD
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 33K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares